Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Dexcom (DXCM) Leases (2019 - 2026)

Dexcom has reported Leases over the past 12 years, most recently at $73.1 million for Q1 2026.

  • Quarterly Leases rose 23.69% to $73.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $73.1 million through Mar 2026, up 23.69% year-over-year, with the annual reading at $77.4 million for FY2025, 23.25% up from the prior year.
  • Leases was $73.1 million for Q1 2026 at Dexcom, down from $77.4 million in the prior quarter.
  • Over five years, Leases peaked at $82.3 million in Q1 2022 and troughed at $54.0 million in Q3 2025.
  • The 5-year median for Leases is $73.1 million (2022), against an average of $70.7 million.
  • Year-over-year, Leases dropped 20.79% in 2025 and then increased 23.69% in 2026.
  • A 5-year view of Leases shows it stood at $80.0 million in 2022, then decreased by 10.75% to $71.4 million in 2023, then dropped by 12.04% to $62.8 million in 2024, then rose by 23.25% to $77.4 million in 2025, then fell by 5.56% to $73.1 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Leases are $73.1 million (Q1 2026), $77.4 million (Q4 2025), and $54.0 million (Q3 2025).